Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Cash from Financing Activities (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Cash from Financing Activities for 3 consecutive years, with -$121000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 303.33% year-over-year to -$121000.0; the TTM value through Dec 2025 reached $9000.0, down 100.0%, while the annual FY2025 figure was $9000.0, 99.99% down from the prior year.
  • Cash from Financing Activities hit -$121000.0 in Q4 2025 for Artiva Biotherapeutics, down from -$37000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $163.9 million in Q3 2024 and bottomed at -$121000.0 in Q4 2025.
  • Average Cash from Financing Activities over 3 years is $23.5 million, with a median of $104500.0 recorded in 2024.
  • Year-over-year, Cash from Financing Activities soared 599.38% in 2024 and then tumbled 303.33% in 2025.
  • Artiva Biotherapeutics' Cash from Financing Activities stood at $962000.0 in 2023, then tumbled by 103.12% to -$30000.0 in 2024, then crashed by 303.33% to -$121000.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$121000.0, -$37000.0, and -$72000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.